PURPOSE: To determine the maximum-tolerated dose (MTD) of iodine-131 (131 I)–labeled 81C6 antitenascin monoclonal antibody (mAb ... for patients with glioblastoma multiforme and for all patients was ...

The data from the city is on a far larger scale than previously released information, and includes all antibody test results ... more lightly across affluent parts of the city.

High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal ... and dosimetric analysis was performed. In all patients with antigen-positive tumors (n = 13), ...

A newly developed radiolabeled antibody that targets the cancer antigen ... were used to determine effective dosimetry of 177 Lu-labeled KLG-3 therapy. Targeting with KLG-3 was also evaluated ...

MorphoSys AG has announced that it has dosed the first patient in a Phase 2 clinical trial of MOR208 in B-cell acute lymphoblastic leukemia (B-ALL). MOR208 is a potent monoclonal Fc optimized ...